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Telemedicine in COPD: An Overview by Topics
Miguel T. Barbosaa,b , Claudia S. Sousab,c, Mario Morais-Almeidab, Maria J. Sim~oesa, and Pedro Mendesc
aPulmonology Department, Hospital Centre of Barreiro-Montijo, Barreiro, Portugal; bAllergy Centre, CUF Descobertas Hospital, Lisboa,
Portugal; cPulmonology Department, Central Hospital of Funchal, Portugal
ABSTRACT
COPD is a major cause of morbidity and mortality worldwide and carries a huge and growing eco-
nomic and social burden. Telemedicine might allow the care of patients with limited access to
health services and improve their self-management. During the COVID-19 pandemic, patient’s
safety represents one of the main reasons why we might use these tools to manage our patients.
The authors conducted a literature search in MEDLINE database. The retrieval form of the Medical
Subject Headings (Mesh) was ((Telemedicine OR Tele-rehabilitation OR Telemonitoring OR mHealth
OR Ehealth OR Telehealth) AND COPD). We only included systematic reviews, reviews, meta-ana-
lysis, clinical trials and randomized-control trials, in the English language, with the selected search
items in title or abstract, and published from January 1st 2015 to 31st May 2020 (n¼ 56). There
was a positive tendency toward benefits in tele-rehabilitation, health-education and self-manage-
ment, early detection of COPD exacerbations, psychosocial support and smoking cessation, but
the heterogeneity of clinical trials and reviews limits the extent to which this value can be under-
stood. Telemonitoring interventions and cost-effectiveness had contradictory results. The literature
on teleconsultation was scarce during this period. The non-inferiority tendency of telemedicine
programmes comparing to conventional COPD management seems an opportunity to deliver
quality healthcare to COPD patients, with a guarantee of patient’s safety, especially during the
COVID-19 outbreak.
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Chronic obstructive pulmonary disease (COPD) is a com-
plex chronic respiratory condition, usually caused by expos-
ure to toxic gases or particles [1]. Worldwide, COPD is a
major cause of morbidity and mortality and carries a huge
and growing economic and social burden [2,3]. Through the
global digital transformation and using the data from the
recently characterized COPD phenotypes, several studies
focusing on the effects of different telemedicine programs
for patients with COPD have been published.
Telemedicine is defined as the use of electronic informa-
tion and communication technology by medical personnel
to provide and support health care to patients when they
are far away from the health care institutions [4,5]. It
encompasses a wide range of technologies such as videocon-
ferencing, wearable devices, internet platforms, mobile appli-
cations, store-and-forward devices, streaming media, and
terrestrial and wireless communication.
Telemedicine can be used for a wide range of purposes,
such as to decrease the demand on existing hospital and
healthcare services, to promote health education, to reduce
the cost of care, to measure and endorse treatment adher-
ence, to quickly identify disease worsening, and to extend
the accessibility of services to patients living in remote loca-
tions. Telemedicine is therefore a broad concept that
involves diagnosis, treatment, monitoring, education and
prevention [6].
The global market of telemedicine, particularly during
this time of the COVID-19 pandemic, has been emerging as
a safer alternative to usual clinical management in chronic
respiratory diseases. In addition, the development of new
technologies, easy to use and inexpensive, will increase the
number of patients requesting telemedicine services.
Nevertheless, details of the implementation of telemedi-
cine interventions in COPD have not been described, and
the effectiveness of telemedicine interventions is still unclear.
Therefore, with this organized review by topics of recent lit-
erature, we attempt to clarify which areas of interest of tele-
medicine in COPD care have been well appraised, which
outcomes we can except from different interventions, and
the possible future programs’ changes to achieve better out-
comes in COPD home-based care.
Material and methods
A literature search was carried out in MEDLINE database,
for peer-reviewed articles published in English language
between January 2015 and June 2020. The retrieval form of
the Medical Subject Headings (Mesh) was: ((Telemedicine
OR Tele-rehabilitation OR Telemonitoring OR mHealth OR
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Ehealth OR Telehealth) AND COPD). Two researchers (CSS
and MTB) independently extracted data from the abstract of
the included studies, being exclusively: systematic reviews,
reviews, meta-analysis, clinical trials and randomized-control
trials, with the search items in title or abstract. A second
assess to eligibility was carried by full-text articles analysis.
Any disagreements during the process were resolved by dis-
cussion with a third researcher (MMA). An additional
search was conducted for relevant recent studies regarding
telemedicine assets on smoking cessation. Ultimately, 56
reports were included in this review (detailed information
about the search methods is illustrated in the flow chart
below—Figure 1).
Literature review
A significant number of reports have been published, evalu-
ating the benefits and limitations of these technologies in
managing and monitoring COPD patients in multiple ways.
This review is organized by four main topics of telemedicine
use in COPD: Tele-rehabilitation, Tele-health education and
self-management, Telemonitoring, and other Mobile applica-
tions and websites. In addition, we reviewed four major
outcomes: exacerbations of COPD and mortality rates; cost-
effectiveness; psychosocial support and smoking cessation.
Tele-rehabilitation
The literature about tele-rehabilitation is plentiful when
applied to COPD patients (Table 1). The majority of the
studies obtained in our search showed either potential or
positive results in augmenting rehabilitation adherence
[7,13] and reduction of healthcare consumption (due to a
decrease in number of COPD exacerbations, emergency
department visits and hospitalizations) [10,16]. Also, it
seems established a gain in quality of life (HRQoL and QoL)
and in exercise tolerance (Six minute walk test) [8,13,15,16].
Likewise, it is noted an improvement in reduction of symp-
toms, increase in exercise capacity or tolerance and sense of
social support [8,13,15]. It seems to be established that
rehabilitation through telemedicine, especially by video plat-
form, is safe [8,15], and well accepted by the patients that
were satisfied with this type of programme [13,15]. A recent
review also stated that it is feasible to deliver teleconsulta-
tions prior the initiation of pulmonary rehabilitation for
rural or remote patients [14].
Tele-health education and self-management
interventions
Tele-health education and self-management is characterized
by certain interventions that empower patients, giving them
the ability to manage by themselves their diseases with
confidence [16]. The complexity of the digital health for
self-management of COPD has escalated with recent
advancement in technology [17]. Many reports attempted to
show the short and long-term benefits of these interventions
in chronic respiratory diseases (Table 2). The majority of
studies determined that telemedicine and e-health interven-
tions have a positive impact in self-management, adherence
to treatment [22,23], quality of life improvement [16,19] and
symptom management ability [22], though a trial by Rixon,
L., et al. [19] specified that telehealth only significantly
improved quality of life in long term follow-ups (compared
Figure 1. Flow chart showing the process of selection of the articles included in our review.
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Table 1. Summary of the studies selected on the topic Tele-rehabilitation applied to patients with COPD.
Author Study design
Publishing date/Country
of Trial Included patients/literature Intervention & Conclusions












 An iRrobot measured pulse
oximetry, forced expiration
volume, heart rate, symptoms,
mental state, and functional
status weekly or as-needed,
provided education about COPD
and inhalation technique, and
reminded patients when to take
medication, inhalers and
rehabilitation exercises.
 This pilot trial suggested that a
robot delivering telehealth care
may be useful for augment
adhesion to rehabilitation
exercises in COPD, although
hospitalizations may not
be reduced.











 Confirmed diagnosis of
CHF (NYHA class II-IV) by
echocardiogram and
COPD (B, C and D GOLD





4-months long included remote
monitoring of cardiorespiratory
parameters, weekly phone-calls
by a nurse, and exercise
programme, monitored weekly
by a physiotherapist.
 Tele-rehabilitation in patients
with COPD and CHF was
feasible, safe, effective and was
able to maintain the results for
6 months with no major side
effects recorded and with a
significant improvement in
exercise tolerance (6MWT), QoL,
dyspnea, physical activity
profile, disability and time-
to-event.








  40 years-old
 COPD diagnosis as
defined by the NICE
COPD guidelines
 COPD patients referred to
pulmonary rehabilitation
 mMRC  2
 Access to the internet
and ability to operate a
web platform
 A 6-week programme of online-
supported PR was non-inferior
to a conventional model
delivered in face-to-face
sessions in terms of effects on
6MWT distance, symptom
scores and it was safe and
well tolerated.









  40 years-old
 COPD diagnosis as
defined in GOLD with






GOLD without regular use
of systemic corticosteroids




 Home-based maintenance tele-
rehabilitation was as effective as
hospital-based, outpatient,
maintenance PR and superior to
usual care in terms of reducing
the risk for acute exacerbation
of COPD and hospitalizations,
while preserving the functional
and HRQoL benefits of a
primary PR programme over a
period of 12 months.
 Moreover, only home-based
maintenance tele-rehabilitation
and not hospital-based,
outpatient, maintenance PR was
an independent predictor of
reduced risk for ER visits.







 Patients who were
referred to a tertiary
hospital PR programme
with a primary medical
diagnosis of stable COPD
 Can operate a computer
independently
(following training)
 Can use a stationary
lower limb cycle
ergometer and a walking
 Telerehabilitation was
conducted as supervised group
exercise training only, three
times a week for 8 weeks. All
participants performed lower
limb cycle ergometry, walking
training and
strengthening exercises.
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to short term follow-ups). These interventions were well
accepted by patients and facilitated doctor-patient relation-
ship [23,25] and transition from inpatient to home-based
care after an exacerbation [21]. Despite the overall positive
outcomes, two studies have shown contradictory results.
One RCT did not manage to find a positive effect on global
health status even though suggesting there may be benefits
in reduced hospital admissions and primary care visits [20]
and another RCT found no significant reduction in




of Trial Included patients/literature Intervention & Conclusions
course independently
at home
 Home walking course of




endurance shuttle walk test
time and self-efficacy, and a
trend toward improvement in
HRQoL when compared with
usual medical care.







 Patients with moderate to
very severe COPD were
eligible in a stable phase
of their disease
 6-months domiciliary bicycle
ergometer training with
telemonitoring in stable COPD.
 Daily training time during the
intervention phase was
significantly superior.
 Telemonitoring of home
exercise cycle training is a
simple method to enhance
physical activity, improving
health-related quality of life of
patients with COPD.





  40 years-old
 COPD diagnosis as
defined in GOLD
 FEV1< 70%
 mMRC dyspnea score  2
 Smoker or smoking
history  10 pack-years
 No respiratory infection
or exacerbation in the 4
weeks prior
 Not having done PR in
the previous 12 months
 Access to a high speed
Internet connection
 8-week in-home pulmonary
telerehabilitation via
videoconference.
 The study showed positive
relevant changes after
telerehabilitation for exercise
tolerance and quality of life.
Users (with moderate or severe
COPD) were very satisfied with
the programme, and adherence
was high.
Selzler, A. M., et al. [14] Review and example Feb, 2018  Literature review focused
on telehealth in
pulmonary rehabilitation
 Teleconsultations have been
shown to be an effective means
to assess patients’ disease prior
to the initiation of PR, and tele-
rehabilitation has been shown
to be as effective as institution-
based PR at improving
functional exercise capacity and
health-related quality of life.
 There is potential of virtual
programs and telemonitoring to
effectively delivery pulmonary
rehabilitation to the rural and
remote patients who are unable
to access a specialized
institution.
Almojaibel, A. A., et al. [15] Review Sep, 2016  Literature review focused
on real-time
telerehabilitation for
COPD patients at home
 Telerehabilitation seems
feasible, accepted, and safe,
besides that it was associated
with positive clinical outcomes
in quality of life, exercise
capacity, dyspnea level, and the
sense of social support.
 Further research with a high
level of evidence investigating
the use of telehealth in
pulmonary rehabilitation is
still needed.
RCT: randomized control trial, TR: Tele-rehabilitation; UC: Usual care; GOLD: Global initiative for chronic obstructive lung disease; NYHA: New York Heart
Association; OR: Outpatient-rehabilitation; 6MWT: Six minute walk test; QoL: quality of life; HRQoL: Health-related quality of life; mMRC: modified Medical
Research Council dyspnea scale; CHF: Chronic heart failure; PR: Pulmonary rehabilitation; FEV1: Forced expiratory volume in 1 s.
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Table 2. Studies selected on the topic Tele-health education and self-management in COPD.
Author Study design
Publishing date/Country
of Trial Included patients/studies Intervention & Conclusions
Kessler, R., et al. [18] RCT
(COMET)





Germany (8), Italy (6),
Spain (7)
  35 years-old
 COPD diagnosis as
defined in GOLD
 FEV1< 50%
 Smoking history >10
pack-years
  1 severe exacerbation
in the previous year









home monitoring and e-health
telephone/web platform for
reporting frequent health status
updates, rapid intervention
when necessary, and oxygen
therapy monitoring).
 High adherence to the
intervention.









Rixon, L., et al. [19] RCT















 There was a trend of improved
QoL and mood in the telehealth
group at longer-term follow-up
(12months), but not short-term
follow-up (6 months).
 Telehealth showed minimal
benefit to QoL in COPD patients
who were not preselected to be
at increased risk of acute
exacerbations.
Farmer, A., et al. [20] RCT
(EDGE)






 Diagnosis of COPD as
defined in GOLD
 Smoking history >10
pack-years
 mMRC dyspnea score 2
 Self-management support using
a Digital Health System (daily
measurement of pulse rate,
SpO2 and symptom scores).
 Tablet computer-based system
of monitoring and self-
management support does not
impact, either positively or
negatively on COPD-specific
health status (SGRQ-C) over a
period of 12 months in severe
COPD patients.
 However, there may be an
overall benefit to patients




Ritchie, C. S., et al. [21] Non-blind RCT





 Patients admitted to the
hospital from home with
CHF or COPD
 Estimated prognosis of
greater than 6 months
 Telephone
 Expected to be
discharged to their home.
 E-Coach technology-assisted
transition from inpatient to
home-based care (CHF and
COPD) after an exacerbation.
 Reduction in 30-day re-
hospitalization rates in COPD
patients when using an
interactive voice response
enhanced care transition.
 No meaningful reduction in
CHF patients.






 Clinical pharmacy telemedicine
interventions in the outpatient
or ambulatory setting, have an
overall positive impact on
outcomes related to clinical
disease management, patient
self-management, and
adherence in the management
of chronic diseases, such as
asthma and COPD.
Morrison D., et al. [23] Review Nov, 2017  Literature review focused
on technology to support
self-management in
asthma and COPD
 New technologies as
smartphone apps, web and
telehealth can facilitate and
promote self-management in
(continued)
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the implemented intervention reduced mortality in severe
COPD patients [18]. Although, there were no reported main
negative effects, further studies are needed to consolidate the
possible impact of these technologies in self-management
and health education in COPD patients [24,26,27].
Telemonitoring
The definition of this concept implies the transmission of
physiologic and other noninvasive data [4]. The literature
obtained by our search was extensive on this topic and the
monitoring assessment and data alerts differed from study
to study as it was already identified [28]. Telemonitoring is
not generally accepted yet because of a lack of compelling
evidence of its beneficial long-term effects and, once again,
the results obtained were mixed (Table 3). Studies report
improvements in some outcomes assessed: quality of life
[12,31], hospital readmissions at three months after dis-
charge [41], and time to readmissions and all cause emer-
gency department or hospital admissions [29,34]. Vianello,
A., et al. contradicts this information, with negative results
in quality of life and a RCT with 578 patients intervened by
Lilholt PH, et al. exposed a non-superior health-related qual-
ity of life in a 12-months follow-up [32,33]. Other data sug-
gests it might not have impact in reducing mortality and
exacerbation-related outcomes in COPD [35], with others
showing reticence regarding the application of these
interventions in a generalized way (34), stating that the ben-
efits might come from the fact that patients submitted to
clinical trials have more attention and support with the dis-
ease than otherwise they would receive. Few reports also
established positive results and possibilities for the successful
application of telemonitoring interventions: with regard to
noninvasive ventilation [38] forced expiratory volume [39],
peripheral oxygen saturation [28,29,42] and physical activity
[12]. There are also investigations into new technologies and
telemonitoring methods with encouraging outcomes, such
as, respiratory oscillometry [30,36,43], exhaled breath tem-
perature [37] or telemonitoring machine learning that will
enable treatments to be personalized and early detect COPD
exacerbations [6,38,40].
Mobile applications and websites
Some recent reviews advocate that mobile applications and
websites might have positive outcomes (Table 4), promoting
self-management, health-education and facilitating the way
healthcare providers meet their patient’s needs [23,48].
However more research is encouraged so that conclusions
can be drawn in the future [47,48] considering that current
information about mobile applications and websites in
COPD health-education, self-management, and physical
activity maintenance after a pulmonary rehabilitation pro-




of Trial Included patients/studies Intervention & Conclusions
both asthma and COPD patients
and facilitate health
professionals to meet their
patient’s treatment goals.










 Through education or as a
component of pulmonary
rehabilitation, self-management
confers significant gain in
health-related quality of life.
Hanlon, P., et al. [24] Review May, 2017  Literature review focused
on telehealth to support
self-management of





consistently superior to usual
care. None of the reviews
assessing mortality in COPD
showed any significant
improvement with telehealth.
No single component was
consistently effective in any
disease area, although none
were associated with harm.
 Larger-scale trials of telehealth-
supported self-management, are
needed before the extent to
which telehealth technologies
may be used to support self-
management can be
established.
TH: Tele-health; QoL: quality of life; UK: United Kingdom; SGRQ-C: St. George’s Respiratory Questionnaire; CHF: Congestive heart failure; UC: Usual care; RCT:
Randomized control trial; GOLD: Global initiative for chronic obstructive lung disease.
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Table 3. Studies selected on the topic telemonitoring in COPD.
Author Study design
Publishing date/Country
of Trial Included patients/studies Intervention & Conclusions
Soriano J. B., et al. [29] Non-blind RCT (PROMETE
II)






 COPD GOLD diagnosis
 Severe airflow obstruction
defined as FEV1< 50%
 Treated with chronic
home oxygen therapy
 2 moderate or severe
exacerbations in the




 Daily telemonitoring of blood
pressure, SpO2, heart rate,
respiratory rate and spirometry
with remote patient
management by a specialized
nurse did not reduce COPD-
related ER visits or hospital
admissions compared to routine
clinical practice.
 A marked but non-significant
trend toward a shorter duration
of hospitalization and days
in ICU.
 The number of all-cause or
respiratory-related deaths was
comparable between groups, as
was total resource
utilization cost.
 There were no differences by
group in anxiety, depression,
daily activity, EQ5D or
COPD symptoms.
 Telehealth was evaluated highly
positively by patients
and doctors.
Walker, P. P., et al. [30] Non-blind RCT









  60 years-old
 COPD GOLD II
 Acute exacerbation with/
without hospitalization in
the previous 12 months











 However, did not affect the
time to first hospitalization,
antibiotic prescriptions,
hospitalization rate, or CAT,
EQ5D and PHQ9
questionnaire scores.
 There was no statistically
significant change in QALYs but
a potentially significant
reduction in the mean cost
per patient.
 In an exploratory analysis,
telemedicine was associated
with fewer repeat
hospitalizations and less total
days hospitalized.
Tupper, O. D., et al. [31] RCT





 COPD GOLD diagnosis
and judged by the study
staff as the leading cause
of disability.
 FEV1< 60%
 Hospital admission due to
COPD exacerbation within
the previous 36 months
and/or prescribed long-
term oxygen therapy due
to chronic respiratory
failure for at least
3 months.
 Regularly scheduled visits
to the respiratory
outpatient clinics.
 Telemonitoring with close
contact between the patient
and the health care providers at
the hospital had a positive
impact on QoL in patients with
more severe COPD.
 Telemonitoring as an add-on to
usual care over a 6-month
period in severe COPD had a




 Future studies should aim at
determining the optimal cutoff
point for health-related QoL
assessment scores to select
good telemonitoring candidates.
Lilholt PH, et al. [32] RCTþ Economic analysis
(TeleCare North)









  2 exacerbations within
the past 12 months
 Motivated for treatment
 In addition to usual care,
patients in the intervention
group received a set of self-
telehealth care equipment
(tablet, sphygmomanometer,
oximeter, scale) and were
(continued)




of Trial Included patients/studies Intervention & Conclusions
 Fixed residence in North
Denmark Region
 mMRC 2 or mMRC  3
and CAT  10
monitored by a community-
based healthcare team.
 There was an indication of
some positive effects on HRQoL
within certain subgroups, but
no statistically significant
differences in HRQoL between
telehealth care and
usual practice.
Vianello, A., et al. [33] Non-blind RCT





 Adult patients diagnosed
with Class III-IV COPD
 Life expectancy >
12 months
 Capability of using, alone
or assisted, the
TM equipment
 Telemonitoring over a 1-year
period had no significant effect
on HRQoL, in preventing
exacerbations or other cause-
related hospitalizations.
 Telemonitoring facilitate
continuity of care during the
hospital-to-home transition,
improving outcomes in patients
discharged after an
exacerbation.
Ho, T., et al. [34] RCT





  20 years-old







 Accessibility to the
internet and phone
at home




outcomes in terms of time to
COPD-related re-admission, and
average number of all-cause re-
admissions and emergency
room visits in the six-month
follow-up.
Li, X., el al [35] Overview of
Systematic Reviews




 Telemonitoring might not
reduce mortality, improve QoL,
exercise capacity, or
exacerbation-related outcomes
in COPD patients. Currently
insufficient clinical evidence to
support the effectiveness of
telemonitoring for COPD.
Kruse, C., et al. [27] Systematic Review Mar, 2019  Literature review focused
on effectiveness of
telemonitoring for COPD
 High variability between the
articles and the telemonitoring
services created conflicting
results: 45% (13/29) stated that
patient outcomes were
improved, while 38% (11/29)
indicated no improvement.
 Authors identified the following
facilitators to the adoption of
telemedicine: reduced need for
in-person visits, better disease
management, and strengthened
patient-provider relationship.




Zimmermann, S. C., et al. [36] Review Mar, 2019  Literature review focused




 Forced oscillation technique
given its effort-independent
nature and ease of






 FOT telemonitoring may enable
early detection of exacerbations,
early treatment and reduction
of health and economic burden
of acute exacerbations.
Popov, T. A., et al. [37] Review Aug, 2017  Literature review focused
on exhaled breath
 Exhaled breath temperature, is
a simple, cheap and
noninvasive tool to assess and
(continued)
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Exacerbations of COPD and mortality rates
Smartphones, artificial intelligence and wearable devices are
emerging (Table 5) and their role for early prediction and
prevention of COPD exacerbations has been rising [17].
The studies in our review reported contradictory outcomes
regarding exacerbation and mortality rates. Hospitalization
and readmissions decreased after implementation of a per-
sonalized care delivered through a web-based call center
[26]. Acute exacerbations of COPD, emergency department
visits and hospital admissions reduced after a tele-rehabili-
tation programme [10,49] and two other telemonitoring
interventions [21,34]. Ding, L., et al. [17] suggested in a
recent review a favorable decrease in exacerbation rate but
with limited or inconsistent evidence. Other recent report
also outlined positive outcomes. Walker, P., et al. [30]
stated that telemonitoring by respiratory oscillometry and
cardiac parameters reduced hospital readmissions and hos-
pitalization length. Intermediate conclusions were obtained
by two systematic reviews: smartphone mediated interven-
tions, when combined with other strategies, might reduce
COPD exacerbations [48] and home monitoring by daily




of Trial Included patients/studies Intervention & Conclusions
temperature in
respiratory medicine
monitor the state of
the airways.
 Ongoing systematic research
will determine its place as a
tool in home monitoring in line
with the modern trends of
personalized and telemedicine.
Arnal, J. M., et al. [38] Review Aug, 2017  Literature review focused
on monitoring of home
noninvasive ventilation
 Telemonitoring might reinforce
and change the organization of
home NIV for COPD patients,
improving daily use and
reducing the number of
treatment discontinuation by
early detection of issues and
problem solving.
Baroi S, et al. [39] Systematic Review Jun, 2018  Literature review focused
on remote respiratory
assessments in COPD
 Forced expiratory volume
assessed daily by using a
spirometer is the most common
modality of remote
respiratory assessment.
 Remote respiratory assessments




outcomes, especially in high-risk
people for acute exacerbations
and who have limited access to
the best care.
Tomasic, I., et al. [40] Review Apr, 2018  Literature review focused
on the available devices
and technologies for the
remote monitoring of
COPD patients
 Remote monitoring systems for
COPD might become integrated
into the personalized medicine,
which will reduce costs and
improve care.
 This will enable the treatments
and care to be tailored to each
patient’s needs based on their
predicted response and
individual risks.
Yang, F., et al. [41] Systematic Review and
Meta-Analysis
Apr, 2017  Literature review focused
on continuity of care to
prevent readmissions for
COPD patients
 Health education reduced all-
cause readmission at 3 months.
The meta-analysis showed that
comprehensive nursing
intervention and telemonitoring
interventions currently have the
best evidence for reducing all-
cause readmissions up to 6
months for patients with COPD.
 However, telemonitoring, action
plan and home visit
interventions did not
reduce mortality.
RCT: randomized control trial, TM: Tele-monitoring; UC: Usual care; GOLD: Global initiative for chronic obstructive lung disease; ICU: intensive care unit; CAT:
COPD Assessment Test; EQ5D: EuroQoL 5 Dimensions; PHQ9: Patient Health Questionnaire-9; HRQoL: Health related quality of life; QoL: quality of life; NIV: non-
invasive ventilation; mMRC: modified Medical Research Council dyspnea scale; SpO2: peripheral oxygen saturation; FOT: Forced oscillation technique; QALY:
Quality-adjusted life year; FEV1: Forced expiratory volume in 1 s.
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Table 4. Studies selected on the topic mobile applications and websites in COPD.
Author Study design
Publishing date/Country
of Trial Included patients / studies Intervention & Conclusions







  40 years-old
 COPD patients GOLD
stage 2 or 3 from 32
physiotherapy practices in
the Netherlands
 Who had completed a
pulmonary rehabilitation
programme of 3 months
within the past 6 months
and lived independently
 mHealth intervention to
stimulate physical activity in
COPD patients after
pulmonary rehabilitation.
The intervention consisted of
a smartphone application for
the patients and a
monitoring website for the
physiotherapists.
 Although functional exercise
capacity did not deteriorate,
our mHealth intervention did
not improve or maintain
physical activity in patients
with COPD after a period of
pulmonary rehabilitation.




 In a general medical
clinic, patients were
approached by study staff
while waiting in the
examination room
 Patients were not
selected on the basis of
having a diagnosis
of COPD
 Evaluation of an iPad
software application to
assess patient’s risk of




 Tablet computers and
mHealth apps for
identification of COPD in




 Future research focused on
the impact and outcomes of
patient-centered, mHealth
apps is warranted.
Marcolino, M., et al. [46] Review Jan, 2018  Literature review focused
on the impact of mHealth
interventions
 Evidence for mHealth
efficacy is still limited. There
is moderate quality evidence
of improvement in asthma
patients and increased
smoking abstinence rates.
 Most studies were performed
in high-income countries,
implying that mHealth is still
at an early stage of
development in low-
income countries.
Hallensleben C., et al. [47] Review Jul, 2019  Literature review focused
on 47 eHealth
applications for COPD in
the Netherlands
 In the Netherlands 47
eHealth applications were




related topics. More research
into the effectiveness
is needed.
 Recommendation to develop




showcased for patients and
health care providers to
improve COPD care.






exacerbations across a wide
variety of contexts.
 There is still need for
more studies.
RCT: randomized control trial, TH: Tele-health; UC: Usual care; GOLD: Global initiative for chronic obstructive lung disease.
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predictor of exacerbation [28]. Nonetheless, more studies
are needed to consolidate these suppositions. More self-
assured was the conclusion of the paper by Shah, S. et al.
that determined pulse oximeter measurements are predict-
ive of COPD exacerbations. Other studies advocated cur-
rently insufficient information on how physiological
parameters (vital signs and lung function) vary prior to
exacerbation to support routine domiciliary monitoring
[50]. In severe COPD patients a remote patient
management did not reduce emergency room visits or hos-
pital admissions [33] despite reducing the duration of both
hospital and ICU stays [29].
Concerning mortality rates, a recent 12-months RCT by
Kessler, R., et al. [18] revealed a reduced acute care hospital-
ization days and mortality rate in severe COPD patients.
Nevertheless, four reviews stated that telemonitoring and
tele-health programs failed to significantly reduce mortal-
ity [24,26,35,41].
Table 5. Summary of the studies selected on the topic exacerbations of COPD.
Author Study design
Publishing date/
Country of Trial Included patients/studies Intervention & Conclusions
Shah, S. A., et al. [42] Analysis from the RCT (EDGE)
EDGE patients (n¼ 110)
Mar, 2017
United Kingdom
 Data from 110 patients
from 1-year long EDGE
clinical trial, with a
combined monitoring
period of more than
35.000 days (average of





 SpO2 was the most
predictive vital sign,
followed by respiratory
rate and pulse rate.
Liu, F., et al. [49] Systematic Review Feb, 2020  Literature review focused
on telemedicine in COPD
in China
 Telemedicine in China
can improve the quality
of life (CAT score) and
reduce the rates of
hospitalization in COPD.







enabled care programs to
reduce hospitalizations
and mortality have been
demonstrated in many
studies, but the clinical
evidence often is limited
and/or inconsistent.




 In many studies,
deviating SpO2 values
were used to raise alerts





 Long-term follow-up of




could be valuable for
exacerbation detections
or predictions.








(vital signs and lung




Ko, F. W., et al. [26] Review Oct, 2016  Literature review focused
on acute exacerbations
management in COPD
 Individually tailored care
plan upon discharge
through a web-based call
center suggested a lower
rate of hospitalization
and readmissions, but no






RCT: randomized control trial, TH: Tele-health; TM: Tele-monitoring; UC: Usual care; GOLD: Global initiative for chronic obstructive lung disease; ICU: intensive
care unit; CAT: COPD Assessment Test; EQ5D: EuroQoL 5 Dimensions; ER: Emergency room; SpO2: peripheral oxygen saturation; HRQoL: Health related quality
of life; CHF: Congestive heart failure; FEV1: Forced expiratory volume in 1 s.
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Table 6. Summary of the studies selected on the topic cost-effectiveness of telemedicine in COPD.
Author Study design
Publishing date/
Country of Trial Included patients/studies Intervention & Conclusions
Mudiyanselage SB, et al. [51] Single-blinded
RCTþ Economic
analysis





 Patients with Diabetes
and/or COPD
 High likelihood of
hospital readmission over
the next 12 months
according to
PRaDA model
 Able to enter and submit




 Lived in their own house
 Willing and able to take
their own vital signs and




exposed a significant saving in
the cost of hospitalization over
12 months, due to a mean
saving of 3.9 bed days, which




outcomes and quality of life
with no additional cost.
Witt Udsen F, et al. [52] RCTþ Economic analysis
(TeleCare North)









  2 exacerbations within
the past 12 months
 Motivated for treatment
 Fixed residence in North
Denmark Region
 mMRC 2 or mMRC  3
and CAT  10
 In addition to usual care,
patients in the intervention
group received a set of
telehealth care equipment and
were monitored by a
community-based
healthcare team.
 Telehealth care is unlikely to be
a cost-effective addition to
usual COPD patients care (non-
significant QALY-gain and
higher costs).










 Telemedicine programs in
general (COPD, Diabetes, CHF)
reduced costs, although
detailed costs data were either
incomplete or not presented
in detail.
RCT: randomized control trial, TH: Tele-health; UC: Usual care; GOLD: Global initiative for chronic obstructive lung disease; mMRC: modified Medical Research
Council dyspnea scale; CAT: COPD Assessment Test; QALY: Quality-adjusted life year; FEV1: Forced expiratory volume in 1 s.
Table 7. Summary of the studies selected on the topic telemedicine psychosocial support in COPD.
Author Study design
Publishing date /
Country of Trial Included patients/studies Intervention & Conclusions
Barken TL, et al. [54] Meta-ethnography Dec, 2019  Literature review focused
on telemedicine in COPD
 Severe COPD patients are more
likely to benefit by
telemedicine, when it involves




Rzadkiewicz M, et al. [55] Review Sep, 2019  Literature review focused
on psychosocial
interventions in COPD
 Self-management and exercise
programs, enriched with digital
monitoring, seem able to reach
most affected patients with
severe COPD (also those with
respiratory failure), improving
their psychosomatic condition.
 Psychosocial interventions by
telehealth with contradictory
results, further studies needed.
Brunton L, et al. [56] Qualitative Meta-synthesis Oct, 2015  Literature review focused
on telehealth user
experience in COPD
 Notable difference between
patients’ and health
professionals’ views and
experiences of telehealth, with
patients being generally more
positive about tele-health use
than health professionals.
RCT: randomized control trial, TH: Tele-health; UC: Usual care; GOLD: Global initiative for chronic obstructive lung disease; EQ5D: EuroQoL 5 Dimensions; SpO2:
peripheral oxygen saturation; FEV1: Forced expiratory volume in 1 s.
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Cost-effectiveness
Although there are numerous studies about telehealth moni-
toring interventions, there is still limited evidence about its
economic evaluation (Table 6). Michaud, T. L., et al. [53]
recent systematic review showed a general reduction in costs
using telemedicine programs in various chronic diseases man-
agement, besides incomplete detailed costs. The existing recent
economic analyses from RCTs showed disparity results in
cost-effectiveness of telemedicine in COPD care [29,51,52].
Psychosocial support
In recent studies, the focus on self-management, tele-
health and pulmonary rehabilitation in both physical and
mental health preservation is noticeable (Table 7). In
advanced stages of COPD, chronic respiratory failure
often develops, which might undermine mental health
and reduce physical activity [55]. Recent outcomes of
reviews about psychosocial support and interventions in
COPD patients using telemedicine seem contradictory
[26,55]. Nonetheless, Mudiyanselage et al., stated an
improvement in anxiety and depression and health liter-
acy with telemedicine [51] and another study reported
that when a programme of telemedicine in severe COPD
involves regular contact with healthcare professionals,
patients are more likely to benefit from it [54]. A posi-
tive effect on well-being, emotional problems and sense
of social support is also described in tele-rehabilitation
programmes [15,55].
Table 8. Summary of the studies selected on the topic telemedicine in smoking cessation.
Author Study design
Publishing date/










  18 years-old




 Ability to interact with
smartphones
 The study aimed to analyze the
long-term efficacy of a mobile
app supporting
psychopharmacological therapy
for smoking cessation and
complementarily assess the
involved innovative technology.
 A mHealth solution/mobile app,
when complementing
psychopharmacological therapy
showed greater efficacy for













  18 years-old
 Recruited offline from 20
primary care and safety
net clinics across Kansas
 Smoke 5 cigarettes/day
for at least 1 year
 Smoke 25 out of the past
30 days
 Speak English or Spanish
 Have a telephone
 4 sessions of ITM or 4 sessions
of Phone counseling. Patients in
ITM received real-time video
counseling, similar to Skype,
delivered by computer/
webcams in clinic exam rooms.
 There was no superiority of
telemedicine over telephone














  18 years-old
 Mexican smokers
interested in quitting
within the next 30 days
 Had smoked for at least
6 months
 Smoked at least 3 days
per week
 had a cell phone with
text messaging capacity
 Willing to complete
baseline and 12-week
follow-up surveys
 Smoking cessation program that
used a tablet-based decision
support software to drive a 12-
week text messaging smoking
cessation program and
pharmacotherapy support.
 Integration of e-Health tools in
primary healthcare settings has
the potential to improve
knowledge about cessation
treatments among smokers and
integrate smoking cessation
into routine of care.




 There is moderate-certainty
evidence that automated text
message-based smoking
cessation interventions can
result in superior quit rates than
minimal smoking
cessation support.
RCT: randomized control trial, TH: Tele-health; ITM: Integrated Telemedicine; UC: Usual care; GOLD: Global initiative for chronic obstructive lung disease.
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Smoking cessation
Our first literature search did not find results regarding tele-
medicine assets on smoking cessation. However, a more glo-
bal search showed some interesting outcomes about
mHealth/mobile applications when complementing psycho-
pharmacological therapy (Table 8), although with some extra
costs [57–59]. In addition, a recent systematic review states
that there is a moderate-certainty evidence that automated
text message-based smoking cessation interventions can
result in superior quit rates than minimal smoking cessation
support [60].
Literature reviews of telemedicine in COPD
Recent literature reviews regarding a general sight of tele-
medicine approaches in COPD care (Table 9) also reported
a positive tendency to telehealth interventions, yet inconclu-
sive clinical enhancements and the need for more standar-
dized trials and systematic reviews [6,61–63].
Discussion
The escalation in complexity and recent advancement in
technology and the need for a safe and efficacious follow-up
put telemedicine in the spotlight. Therefore, in the past five
years, some fallouts have been pointed out regarding tele-
medicine use in COPD management.
Concerning tele-rehabilitation, our review supports that it
seems a feasible and safe alternative to face-to-face pulmon-
ary rehabilitation with an established non-inferiority of
major clinical outcomes, such as exercise tolerance, dyspnea
level and quality of life [14,15].
Digital health solutions regarding telemonitoring of
COPD patients obtained contradictory outcomes, partly
because of technical difficulties and low patient compliance.
To address these matters, an integrative approach, possibly
with continuous improvement and monitoring, seems essen-
tial [47]. Another important feature that optimizes the use
of telemonitoring is to implement flexible systems that can
be customized to individual patients’ requirements, adapted
to our diverse healthcare contexts and to correctly identify
who the ideal candidates are, at what time they need it, and
for how long [6]. Additionally, COPD patients are a very
heterogeneous population with different phenotypes, with an
overall decline in health status and a variable baseline
physiological parameters [40]. Therefore, future research
could optimize self-management by using individualized,
time-dependent thresholds or predictive algorithms to
account for individual differences, diminishing false-alerts,
anxiety and lack of compliance [28]. Moreover, artificial
intelligence and wearable devices are emerging and finding
their way into the health sector and may provide new
opportunities for early prediction and prevention of COPD
exacerbation, diminishing hospitalizations, emergency room
visits and hospital services burden, which would be espe-
cially useful during the current pandemic [17,55].
Unexpectedly, none of the reviews assessing mortality in
COPD showed a statistically significant improvement within
telemedicine programs [24].
COPD is often accompanied by anxiety disturbance,
depression, lack of social support, and feeling of isolation.
The majority of the reports about psychosocial support
interventions or that considered the patients quality of life
and general satisfaction about the telemedicine intervention
got favorable outcomes, especially with regular contact with
healthcare professionals [55,61].
Future clinical trials should include a cost analysis in
their reporting to provide financial insights related to the
implementation of the intervention [61]. The lack of detailed
data on program costs and health-care service savings make
it tricky for home-based telemedicine programs to make a
solid economic case when considering reimbursement or
investment in these programs [53].
Table 9. Summary of other recent literature reviews about Telemedicine in COPD management.
Author Study design Publishing date Main conclusions
Gaveikaite, V., et al. [61] Review Sep, 2019  Positive tendency of European telehealth interventions to positive outcomes, but the
heterogeneity of clinical trials and systematic reviews limits the extent to which this
value can be understood.
 Need for more standardized methods and updated systematic reviews.
Vitacca, M., et al. [6] Review Jan, 2018  The overall extent and significance of benefits to patients and economic organizational
expectations are not always consistent, however telemedicine will provide a
framework for patient care, changing the future clinical practice and implementing
flexible systems that can be customized to individual COPD patients’ requirements.
Ambrosino, N., et al. [62] Review Nov, 2017  Telemedicine might allow the care of patients with limited access to health services,
and improve their self-management.
 Controlled trials have investigated the feasibility, cost-effectiveness, security, and
perspectives of tele-medicine; nevertheless, current literature is inconclusive on the
real clinical benefits.
Ambrosino, N., et al. [63] Review Apr, 2017  Telemedicine can improve the care of patients with difficult access to services,
particularly those in rural/remote areas. However, this approach might be an alibi to
reduce standard services in more developed health systems.
 Despite the hopes in telemedicine as a means of patients’ care, we need much more
evidence before this modality can be considered as a real improvement in the
management of patients.
 The legal problems are still to be solved. Regulators must indicate ethical, legal,
regulatory, technical, and administrative standards.
 Much more research is needed before considering telemedicine a standard
management of these patients.
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Patients’ age, education, experience in technological devi-
ces, cognitive, motor and visual abilities or deficits, their
families and home environment play an important role in
the use of technologies [62]. Therefore, technology-based
interventions may not be as effective in some populations,
what might limit the wider diffusion of telemedicine pro-
grams [64]. In this review the majority of the trials were
grounded on high income countries which may not reflect
the outcomes in less developed countries/areas. Nevertheless,
the tendency for low cost technology, its wide spread
throughout the world in different social/age groups and add-
itional training in communication technology of the popula-
tion, might balance this matter in a near future.
In this COVID-19 pandemic time, we are currently lim-
ited in our abilities to diagnose, monitor and manage
chronic airway diseases in face-to-face consultations [36].
Surprisingly, none of the included studies intentionally ana-
lyzed COPD teleconsultations via telephone or videoconfer-
ence as first doctor-patient, follow-up or second opinion
medical consultations [14]. We consider it is a gap which
necessarily should be complemented to the evolution of tele-
medicine in COPD as a cost-effective and safer health care
alternative [65,66].
In conclusion, there was a positive tendency toward bene-
fits in tele-rehabilitation, health-education and self-manage-
ment, early detection of COPD exacerbations, psychosocial
support and smoking cessation. Telemonitoring interven-
tions and cost-effectiveness had contradictory results. The
extent and significance of benefits to patients and health-
care organizations were not always consistent.
An important limitation of this study is that it only
included articles written in English. Other important limita-
tions are the short follow-up period, the small sized popula-
tion studies and the different inclusion criteria of the
majority of the RCTs/reviews included in this report which
restrict conclusions and clinical recommendations.
Telemedicine itself seems to be not sufficient to yield a
significantly better outcome, but it could be a key add-on in
COPD care, especially in the COVID-19 pandemic, reducing
both inpatient and outpatient health care burden.
In this time of major health services demand and very
unique infection control concerns with the COVID-19 pan-
demic, a non-inferiority in the main outcomes of telemedi-
cine programs presented in this review seems significant. It
is quite likely that from now on telemedicine will allow sig-
nificant changes in our clinical practice.
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